论文部分内容阅读
目的探讨经阿替普酶溶栓治疗急性ST段抬高型心肌梗死患者的临床效果。方法随机从我院2012年3月至2015年3月急诊科收治的急性ST段抬高型心肌梗死患者中抽取72例进行研究,并对其临床治疗进行回顾性分析。结果 1本组患者共有62例再通,再通率为86.11%。2本组患者共有24例在随访中出现不良反应,发生率为33.33%。结论急性ST段抬高型心肌梗死患者经阿替普酶溶栓治疗具有显著的治疗效果,再通率较高,具有较高的临床推广价值。
Objective To investigate the clinical effect of intravenous alteplase in patients with acute ST-segment elevation myocardial infarction. Methods A total of 72 patients with acute ST-segment elevation myocardial infarction who were admitted to the emergency department from March 2012 to March 2015 in our hospital were randomly divided into two groups. The clinical data were retrospectively analyzed. Results A total of 62 patients in this group recanalization, the recanalization rate was 86.11%. A total of 24 patients in this group of patients showed adverse reactions during follow-up, the incidence was 33.33%. Conclusion Acute ST-segment elevation myocardial infarction patients with alteplase thrombolytic therapy has a significant therapeutic effect, a high recanalization rate, with high clinical value.